Back to Trades
Smith Jason Drew
General CounselCIK 0001821479
Total Volume
$384.9K
4 filings
Purchases
$0
0 buy txns
Sales
$384.9K
6 sell txns
Net Activity
-$384.9K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Smith Jason Drew, General Counsel, has filed 4 SEC reports (2025–2026), all concentrated in UroGen Pharma Ltd. (URGN), totaling $384.9K in disclosed volume. Weighing $0 bought versus $384.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 9 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $64.6K |
| Feb 11 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $147.3K |
| Sep 9 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $29.0K |
| Jul 30 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $144.0K |
4 filings